{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:31:11Z","timestamp":1780669871192,"version":"3.54.1"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>People who inject drugs have a substantial risk for HIV infection, especially women who inject drugs (WWID). HIV pre-exposure prophylaxis (PrEP), a highly-effective HIV prevention drug, is uncommonly studied among WWID, and we aimed to synthesize existing knowledge across the full PrEP continuum of care in this population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We systematically searched for peer-reviewed literature in three electronic databases, conference abstracts from three major HIV conferences, and gray literature from relevant sources.<\/jats:p><jats:p>Eligibility criteria included quantitative, qualitative or mixed-methods studies with primary data collection reporting a PrEP-related finding among WWID, and published in English or Spanish between 2012 and 2021. The initial search identified 2,809 citations, and 32 were included. Data on study characteristics and PrEP continuum of care were extracted, then data were analyzed in a narrative review.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our search identified 2,809 studies; 32 met eligibility requirements. Overall, awareness, knowledge, and use of PrEP was low among WWID, although acceptability was high. Homelessness, sexual violence, unpredictability of drug use, and access to the healthcare system challenged PrEP usage and adherence. WWID were willing to share information on PrEP with other WWID, especially those at high-risk of HIV, such as sex workers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>To improve PrEP usage and engagement in care among WWID, PrEP services could be integrated within gender-responsive harm reduction and drug treatment services. Peer-based interventions can be used to improve awareness and knowledge of PrEP within this population. Further studies are needed on transgender WWID as well as PrEP retention and adherence among all WWID.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2022.951682","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T09:00:31Z","timestamp":1661504431000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["The HIV pre-exposure prophylaxis continuum of care among women who inject drugs: A systematic review"],"prefix":"10.3389","volume":"13","author":[{"given":"Danielle","family":"Guy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Doran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trenton M.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"van Selm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teymur","family":"Noori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey V.","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,26]]},"reference":[{"key":"B1","unstructured":"2020"},{"key":"B2","unstructured":"2018"},{"key":"B3","doi-asserted-by":"publisher","first-page":"S176","DOI":"10.1097\/QAI.0000000000000659","article-title":"HIV, HCV, and health-related harms among women who inject drugs: implications for prevention and treatment","volume":"69","author":"Iversen","year":"2015","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B4","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1097\/QAI.0000000000000624","article-title":"Substance use and hiv among female sex workers and female prisoners: risk environments and implications for prevention, treatment, and policies","volume":"69","author":"Strathdee","year":"2015","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"S182","DOI":"10.1097\/QAI.0000000000000628","article-title":"Women who use or inject drugs: an action agenda for women-specific, multilevel, and combination HIV prevention and research","volume":"69","author":"El-Bassel","year":"2015","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B6","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/QAD.0000000000000948","article-title":"Sex work and HIV incidence among people who inject drugs","volume":"30","author":"Kerr","year":"2016","journal-title":"AIDS."},{"key":"B7","doi-asserted-by":"publisher","first-page":"108706","DOI":"10.1016\/J.DRUGALCDEP.2021.108706","article-title":"The intersection of gender and drug use-related stigma: a mixed methods systematic review and synthesis of the literature","volume":"223","author":"Meyers","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"B8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/J.SOCSCIMED.2019.01.022","article-title":"A qualitative study on intersectional stigma and sexual health among women on opioid substitution treatment in England: implications for research, policy and practice","volume":"222","author":"Medina-Perucha","year":"2019","journal-title":"Soc Sci Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.drugpo.2014.09.003","article-title":"Women, drugs and HIV","volume":"26","author":"Azim","year":"2015","journal-title":"Int J Drug Policy."},{"key":"B10","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1089\/APC.2016.0098","article-title":"The potential of pre-exposure prophylaxis for women in violent relationships","volume":"30","author":"Braksmajer","year":"2016","journal-title":"AIDS Patient Care STDS."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1097\/QAD.0000000000001145","article-title":"Effectiveness and safety of oral HIV preexposure prophylaxis for all populations","volume":"30","author":"Fonner","year":"2016","journal-title":"AIDS."},{"key":"B12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s15010-015-0850-2","article-title":"HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans","volume":"44","author":"Spinner","year":"2016","journal-title":"Infection"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-016-1286-4","article-title":"An analysis of baseline data from the PROUD study: An open-label randomised trial of pre-exposure prophylaxis","volume":"17","author":"Dolling","year":"2016","journal-title":"Trials."},{"key":"B14","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1071\/SH18182","article-title":"Getting pre-exposure prophylaxis (PrEP) to the people: opportunities, challenges and examples of successful health service models of PrEP implementation","volume":"15","author":"Zablotska","year":"2018","journal-title":"Sex Health."},{"key":"B15","unstructured":"2015"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e502","DOI":"10.1016\/S2352-3018(21)00127-2","article-title":"Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study.","volume":"8","author":"Schaefer","year":"2021","journal-title":"Lancet HIV."},{"key":"B17","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/QAD.0000000000001385","article-title":"Defining the HIV pre-exposure prophylaxis care continuum","volume":"31","author":"Nunn","year":"2017","journal-title":"AIDS"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1007\/s10461-020-02988-x","article-title":"The pre-exposure prophylaxis (PrEP) care cascade in people who inject drugs: a systematic review","volume":"25","author":"Mistler","year":"2021","journal-title":"AIDS Behav."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1007\/s10461-019-02733-z","article-title":"The PrEP care continuum among cisgender women who sell sex and\/or use drugs globally: a systematic review","volume":"24","author":"Glick","year":"2020","journal-title":"AIDS Behav"},{"key":"B20","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3233\/EFI-180221","article-title":"The mixed methods appraisal tool (MMAT) version 2018 for information professionals and researchers","volume":"34","author":"Hong","year":"2018","journal-title":"Educ Inf."},{"key":"B21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1177\/1078345813518631","article-title":"Seroconversion risk perception among jail populations: a call for gender-specific HIV prevention programming","volume":"20","author":"Alarid","year":"2014","journal-title":"J Correct Heal care Off J Natl Comm Correct Heal Care."},{"key":"B22","volume-title":"Sometimes You Gotta Choose: An Indepth Qualitative Analysis on Perceptions of the Barriers and Facilitators to use and Adhere to PrEP in Women Who Inject Drugs","author":"Bass","year":"2019"},{"key":"B23","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1089\/apc.2018.0126","article-title":"Limited knowledge and mixed interest in pre-exposure prophylaxis for hiv prevention among people who inject drugs","volume":"32","author":"Bazzi","year":"2018","journal-title":"AIDS Patient Care STDS."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0247352","DOI":"10.1371\/journal.pone.0247352","article-title":"Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: results from a multi-city cross-sectional survey","volume":"16","author":"Belludi","year":"2021","journal-title":"PLoS ONE."},{"key":"B25","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s10461-014-0867-z","article-title":"Acceptability of HIV pre-exposure prophylaxis (PREP) among people who inject drugs (PWID) in a Canadian setting","volume":"19","author":"Escudero","year":"2015","journal-title":"AIDS Behav."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1007\/s10508-020-01684-0","article-title":"An exploration of pre-exposure prophylaxis (PrEP) initiation among women who inject drugs","volume":"49","author":"Felsher","year":"2020","journal-title":"Arch Sex Behav."},{"key":"B27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1177\/1049732320952740","article-title":"Motivations for PrEP-related interpersonal communication among women who inject drugs: a qualitative egocentric network study","volume":"31","author":"Felsher","year":"2020","journal-title":"Qual Health Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1521\/aeap.2020.32.6.486","article-title":"Applying the behavioral model for vulnerable populations to pre-exposure prophylaxis initiation among women who inject drugs","volume":"32","author":"Felsher","year":"2020","journal-title":"AIDS Educ Prev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"113809","DOI":"10.1016\/j.socscimed.2021.113809","article-title":"\u201cPrEP just isn't my priority\u201d: Adherence challenges among women who inject drugs participating in a pre-exposure prophylaxis (PrEP) demonstration project in Philadelphia","volume":"275","author":"Felsher","year":"2021","journal-title":"Soc Sci Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1007\/s10461-021-03312-x","article-title":"The influence of PrEP-related stigma and social support on PrEP-Use disclosure among women who inject drugs and social network members","volume":"25","author":"Felsher","year":"2021","journal-title":"AIDS Behav."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1080\/09540121.2019.1587352","article-title":"Exploring new and existing PrEP modalities among female sex workers and women who inject drugs in a U.S. city.","volume":"31","author":"Footer","year":"2019","journal-title":"AIDS Care Psychol Soc Med Asp."},{"key":"B32","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1089\/trgh.2020.0003","article-title":"Willingness to use pre-exposure prophylaxis (PrEP) for HIV prevention and PrEP implementation preferences among transgender women in Malaysia","volume":"5","author":"Galka","year":"2020","journal-title":"Transgender Heal."},{"key":"B33","volume-title":"Pre-Exposure Prophylaxis (PrEP) for People Who Inject Drugs: Community Voices on Pros, Cons, and Concerns","year":"2016"},{"key":"B34","volume-title":"Key Populations' Values and Preferences for HIV, Hepatitis, and STI Services: A Qualitative Study","year":"2021"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0231424","DOI":"10.1371\/journal.pone.0231424","article-title":"Interest in linkage to PrEP among people who inject drugs accessing syringe services; Miami, Florida","volume":"15","author":"Jo","year":"2020","journal-title":"PLoS ONE."},{"key":"B36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.drugalcdep.2016.02.044","article-title":"Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC","volume":"164","author":"Kuo","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"B37","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1097\/QAD.0000000000000613","article-title":"The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs","volume":"29","author":"Martin","year":"2015","journal-title":"Aids."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1016\/S2352-3018(16)30207-7","article-title":"Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people who have injected drugs: an observational, open-label extension of the Bangkok Tenofovir study","volume":"4","author":"Martin","year":"2017","journal-title":"lancet HIV."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1007\/s10461-019-02682-7","article-title":"Low PrEP awareness and use among people who inject drugs, San Francisco, 2018","volume":"24","author":"McFarland","year":"2020","journal-title":"AIDS Behav."},{"key":"B40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/02791072.2016.1259518","article-title":"Racial differences in HIV and HCV risk behaviors, transmission, and prevention knowledge among non-treatment-seeking individuals with opioid use disorder","volume":"49","author":"Metz","year":"2017","journal-title":"J Psychoactive Drugs."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1080\/09540121.2017.1300628.Acceptability","article-title":"Acceptability of pre-exposure prophylaxis and vaginal rings for HIV prevention among female sex workers in Baltimore, MD","volume":"29","author":"Peitzmeier","year":"2017","journal-title":"AIDS Care Psychol Soc Med Asp."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2325958219900091","article-title":"Women's decision-making about PrEP for HIV prevention in drug treatment contexts","volume":"19","author":"Qin","year":"2020","journal-title":"J Int Assoc Provid AIDS Care."},{"key":"B43","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/OLQ.0000000000000728","article-title":"An exploration of factors impacting preexposure prophylaxis eligibility and access among syringe exchange users","volume":"45","author":"Roth","year":"2018","journal-title":"Sex Transm Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1007\/s10461-018-2293-0","article-title":"Factors associated with awareness of pre-exposure prophylaxis for hiv among persons who inject drugs in philadelphia: national hiv behavioral surveillance, 2015","volume":"23","author":"Roth","year":"2019","journal-title":"AIDS Behav."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1097\/QAI.0000000000002558","article-title":"Integrating HIV preexposure prophylaxis with community-based syringe services for women who inject drugs: results from the project SHE demonstration study","volume":"86","author":"Roth","year":"2021","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B46","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1080\/09540121.2020.1822506","article-title":"Awareness of and interest in oral pre-exposure prophylaxis (PrEP) for HIV prevention and interest in hypothetical forms of PrEP among people who inject drugs in rural West Virginia","volume":"33","author":"Schneider","year":"2021","journal-title":"AIDS Care"},{"key":"B47","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/J.DRUGALCDEP.2018.08.014","article-title":"PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland","volume":"195","author":"Sherman","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1007\/s10461-014-0778-z","article-title":"Willingness to use HIV pre-exposure prophylaxis among opiate users","volume":"18","author":"Stein","year":"2014","journal-title":"AIDS Behav."},{"key":"B49","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1080\/09540121.2021.1874267","article-title":"Intention to initiate and uptake of PrEP among women who injects drugs in a demonstration project: an application of the theory of planned behavior","volume":"33","author":"Tran","year":"2021","journal-title":"AIDS Care."},{"key":"B50","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12954-017-0166-x","article-title":"Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention","volume":"14","author":"Walters","year":"2017","journal-title":"Harm Reduct J."},{"key":"B51","doi-asserted-by":"publisher","first-page":"S383","DOI":"10.1097\/QAI.0000000000001415","article-title":"Differences in awareness of pre-exposure prophylaxis and post-exposure prophylaxis among groups at-risk for HIV in New York State: New York City and Long Island, NY, 2011-2013","volume":"75","author":"Walters","year":"2017","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B52","doi-asserted-by":"crossref","first-page":"108525","DOI":"10.1016\/j.drugalcdep.2021.108525","article-title":"Age and gender-specific hepatitis C continuum of care and predictors of direct acting antiviral treatment among persons who inject drugs in Seattle, Washington","volume":"220","author":"Corcorran","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-018-0263-5","article-title":"Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs","volume":"15","author":"Biello","year":"2018","journal-title":"Harm Reduct J."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1007\/s10461-020-03115-6","article-title":"Predictors of willingness to diffuse PrEP information within ego-centric networks of women who inject drugs","volume":"25","author":"Felsher","year":"2021","journal-title":"AIDS Behav."},{"key":"B55","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/09540121.2017.1363369","article-title":"Perspectives on biomedical HIV prevention options among women who inject drugs in Kenya","volume":"30","author":"Bazzi","year":"2018","journal-title":"AIDS Care Psychol Soc Med Asp."},{"key":"B56","unstructured":"2019"},{"key":"B57","unstructured":"2010"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e0230886","DOI":"10.1371\/journal.pone.0230886","article-title":"Gender-based vulnerability in women who inject drugs in a harm reduction setting","volume":"15","author":"Valencia","year":"2020","journal-title":"PLoS ONE."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40352-015-0015-5","article-title":"Pregnant women and substance use: fear, stigma, and barriers to care","volume":"3","author":"Stone","year":"2015","journal-title":"Heal Justice."},{"key":"B60","unstructured":"2019"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1007\/S10461-019-02573-X","article-title":"Suboptimal HIV pre-exposure prophylaxis awareness and willingness to use among women who use drugs in the United States: a systematic review and meta-analysis","volume":"23","author":"Zhang","year":"2019","journal-title":"AIDS Behav."},{"key":"B62","doi-asserted-by":"publisher","first-page":"21580","DOI":"10.7448\/IAS.20.1.21580","article-title":"Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low- and middle-income countries: a systematic review and meta-analysis","volume":"20","author":"Yi","year":"2017","journal-title":"J Int AIDS Soc."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1080\/13691058.2016.1164899","article-title":"When and why women might suspend PrEP use according to perceived seasons of risk: implications for PrEP-specific risk-reduction counselling","volume":"18","author":"Namey","year":"2016","journal-title":"Cult Heal Sex."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1007\/S10461-015-1238-0","article-title":"Seasons of risk: anticipated behavior on vacation and interest in episodic antiretroviral pre-exposure prophylaxis (PrEP) among a large national sample of U.S. Men who have sex with Men (MSM)","volume":"20","author":"Elsesser","year":"2016","journal-title":"AIDS Behav."},{"key":"B65","volume-title":"HIV Pre-Exposure Prophylaxis in the EU\/EEA and the UK: Implementation, Standards and Monitoring Operational Guidance","year":"2019"},{"key":"B66","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/J.DRUGPO.2018.04.004","article-title":"Stigma at every turn: health services experiences among people who inject drugs","volume":"57","author":"Paquette","year":"2018","journal-title":"Int J Drug Policy."},{"key":"B67","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1007\/s10461-018-2184-4","article-title":"Improving PrEP implementation through multilevel interventions: a synthesis of the literature","volume":"22","author":"Pinto","year":"2018","journal-title":"AIDS Behav."},{"key":"B68","doi-asserted-by":"publisher","first-page":"103033","DOI":"10.1016\/J.DRUGPO.2020.103033","article-title":"Perspectives on pre-exposure prophylaxis for people who inject drugs in the context of an hiv outbreak: a qualitative study","volume":"88","author":"Smith","year":"2021","journal-title":"Int J Drug Policy."},{"key":"B69","doi-asserted-by":"crossref","DOI":"10.7448\/IAS.19.7.21112","article-title":"Commentary: the value of PrEP for people who inject drugs","volume-title":"J Int AIDS Soc.","author":"Coleman","year":"2016"},{"key":"B70","doi-asserted-by":"publisher","first-page":"e86584","DOI":"10.1371\/JOURNAL.PONE.0086584","article-title":"Effectiveness and cost effectiveness of oral pre-exposure prophylaxis in a portfolio of prevention programs for injection drug users in mixed HIV epidemics","volume":"9","author":"Alistar","year":"2014","journal-title":"PLoS ONE."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12954-020-00395-Y","article-title":"Providing reproductive health services for women who inject drugs: a pilot program","volume":"17","author":"Owens","year":"2020","journal-title":"Harm Reduct J. 2020 171."},{"key":"B72","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12954-018-0214-1","article-title":"\u201cThey accept me, because I was one of them\u201d: formative qualitative research supporting the feasibility of peer-led outreach for people who use drugs in Dakar, Senegal","volume":"15","author":"Stengel","year":"2018","journal-title":"Harm Reduct J"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12954-022-00595-8\/TABLES\/1","article-title":"The impact of peer support on testing, linkage to and engagement in HIV care for people who inject drugs in Indonesia: qualitative perspectives from a community-led study","volume":"19","author":"Iryawan","year":"2022","journal-title":"Harm Reduct J."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.951682\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T09:00:45Z","timestamp":1661504445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.951682\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":73,"alternative-id":["10.3389\/fpsyt.2022.951682"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2022.951682","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,26]]},"article-number":"951682"}}